Atypical course of COVID-19 in patient with Bruton agammaglobulinemia

Abstract

We present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inhibitor.

Keywords

• COVID-19
• agammaglobulinemia
• convalescent plasma
• IL-6 inhibitor